This financial contribution will enable the Catalan biotech company to advance the development of new drugs targeting therapeutic targets traditionally considered intractable, such as intrinsically di...
Read moreThe new study, conducted in animal models, describes a repressor factor that blocks brown fat activity: the ACBP protein. Under normal conditions, this protein would regulate when brown fat activity i...
Read moreBeCytes Biotechnologies opens a new laboratory in the Barcelona Science Park (PCB) with the aim of boosting its international growth. The biotechnology company focuses its activity on the management o...
Read moreMaria Terrades: “Scientific knowledge, cutting-edge research and entrepreneurial vision converge at the PCB, facilitating collaboration and knowledge transfer”.
Read moreMaternal spindle transfer, commonly known as the “three-parent technique,” involves placing the mother’s DNA into a high-quality egg from a fertile donor, which is then fertilized with the fathe...
Read moreCONNECTA Therapeutics, a clinical-stage biotech company located at the Barcelona Science Park (PCB), which leads the development of first-in-class neuroplasticity modulators to address unmet medical n...
Read moreDeveloped under the principles of green chemistry, PLH is the first biocompatible, thermosetting and highly flexible copolyester on the market obtained from 100% bio- based raw materials. It is emergi...
Read moreResearchers from the National Centre for Genomic Analysis (CNAG), located at the Barcelona Science Park, have collaborated in a study led by the UK National Measurement Laboratory (NML) with the aim o...
Read moreIt has been shown that cell-free supernatants of Bifidobacterium longum subsp. infantis CECT 7210 and Lacticaseibacillus paracasei CECT 30660 reduce inflammation during pregnancy and show preventive p...
Read moreA public-private consortium led by the biotechnology company Nuage Therapeutics has initiated the development of an innovative therapy against the most frequent subtype of small cell lung cancer (SCLC...
Read moreThe U.S. multinational BioIVT, a global leader in the development of high-quality biological samples and research services for drug and diagnostic development, has acquired the Catalan company BeCytes...
Read moreThis new platform aims to support both internal and external researchers in the study of cellular metabolism, a key field for understanding fundamental processes such as ageing, metabolic diseases, ca...
Read more